Journal list menu
Export Citations
Download PDFs
Clinical Study
Open Access
oa
Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?
- First Published: 23 October 2017